A 30ml vial offers the most flexibility for multi-dose use, while 10ml vials are ideal for shorter-run preparations
This, in turn, boosts metabolic rate and activates a gene known as sirtuin-1 (SIRT1), also referred to as the "longevity gene." SIRT1 is involved in reducing the risk of various conditions such as diabetes, obesity, metabolic syndrome, atherosclerosis, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
This trial bridged the gap between the weight-management and diabetes programs, confirming that tirzepatide produces substantial weight loss even in patients with T2D, a population historically harder to treat with anti-obesity medications
Your provider may recommend restarting at a lower dose if the gap extends beyond two weeks, especially if you are taking a higher maintenance dose
and Metabolism 24, 10761082